“…The I Kr protein is encoded by a HERG gene, while I Ks is the result of assembly of hKCNQ1 (the alpha subunit of I Ks ) and minK (the beta subunit), encoded by hKCNQ1 and hKCNE1 genes, respectively. Overt mutations and/or DNA polymorphisms in these genes, especially when associated to non-genetic causes, such as bradycardia, hypokalemia, female gender… [3,4] may decrease the function of their products leading to a prolong QT interval (congenital or acquired long QT syndrome, LQTS). Amiodarone, a widely used class III antiarrhythmic drug, block the I Kr and I Ks components of the delayed rectifier potassium channel, the slow inward Ca 2+ current mediated through the L-calcium channels and has a noncompetitive antisympathetic effect; usually, and as a result, it may prolong, even uniformly and in a modest proportion, the QT interval; however, when a subclinical deficiency in genes encoding potassium channel is present, an unexpected, acquired QT interval lengthening may result (aLQTS) [5].…”